October 21st at 18:00 virtual event Dr. Aviv Regev, Genentech Inc., US Cell Atlases as roadmaps to treat disease host: Riitta Lahesmaa (riitta.lahesmaa@utu.fi) Register latest on Read more
According to the study led by Professor Matej Orešič and Professor Tuulia Hyötyläinen, women are more affected than men when they are exposed to PFAs. A Read more
Joni Merisaari researched cellular vulnerabilities of glioblastoma. His thesis work was done under the supervision of Professor Jukka Westermarck in the Cancer Cell Signaling lab. Read more
Immunology Seminar October 19th at 14:00 – 15:00 Virtual event Ilkka Junttila, Tampere University Cytokine Landscape of Allergic Inflammation Host: Riitta Lahesmaa (rilahes@utu.fi) Register latest Read more
Turku Bioscience is proud to announce that Johanna Ivaska has received Academy of Finland funding for her Center of Excellence ”Biological Barrier Mechanics and Disease: Read more
MSc Mitro Miihkinen from Westermarck Lab defends his dissertation in Cell Biology and Anatomy entitled ”NOVEL INSIGHTS INTO FILOPODIA FUNCTION – A focus on integrin Read more
Martina Lerche studied how the crosstalk between the extracellular matrix (ECM) and integrin adhesion receptors regulate cell behavior. The studies were carried out under the Read more
September 21st at 14-15 Virtual event Flyer Satu Mustjoki, University of Helsinki: Somatic mutations in (non-malignant) immune-mediated diseases Host: Riitta Lahesmaa ( rilahes (at) Read more
BioCity Turku arranges every semester Frontiers of Science seminar series where researchers are welcome to invite prominent international scientists to give a talk to local Read more
Yearly BioCity Symposium is almost here! We have decided to prolong the registration time with one week, until Friday 13th August at 15:00. Register Read more
Turku Screening Unit have acquired a second High-throughput imager, which Read more
Last updated on June 25, 2025
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
